reports
- GlobalData Department
Genomic Vision (GV) - Product Pipeline Analysis, 2018 Update
Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for identifying and characterizing rearrangements which affect the BRCA1 and BRCA2 genes. Its diagnostic tests are based on DNA molecular combing technology. Genomic’s technolo...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.